The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility

The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta-analysis...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 11; no. 1; pp. 18619 - 12
Main Authors Tan, Shing Cheng, Low, Teck Yew, Mohamad Hanif, Ezanee Azlina, Sharzehan, Mohamad Ayub Khan, Kord-Varkaneh, Hamed, Islam, Md Asiful
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 20.09.2021
Nature Publishing Group
Nature Portfolio
Subjects
631/208
631/67
692/4028/67/1347
692/4028/67/1857
692/4028/67/68
692/53/2421
692/53/2423
692/699/67/1347
Adult
Alleles
Breast cancer
Breast Neoplasms - genetics
Estrogen Receptor alpha - genetics
Estrogen receptors
Estrogens
Female
Gene polymorphism
Genetic Association Studies
Genetic markers
Genetic Predisposition to Disease
Humanities and Social Sciences
Humans
Menopause
Meta-analysis
Middle Aged
multidisciplinary
Polymorphism
Polymorphism, Single Nucleotide
Science
Science (multidisciplinary)
Statistical analysis
Susceptibility
Online AccessGet full text

Cover

Abstract The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta-analysis. Eligible studies were identified from the Web of Science, PubMed, Scopus, China National Knowledge Infrastructure, VIP and Wanfang databases based on the predefined inclusion and exclusion criteria. The pooled odds ratio (OR) was then calculated under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). Combined results from 23 studies involving 34,721 subjects indicated a lack of significant association between the polymorphism and BC susceptibility (homozygous model, OR = 1.045, 95% CI 0.887–1.231, P = 0.601; heterozygous model, OR = 0.941, 95% CI 0.861–1.030, P = 0.186; dominant model, OR = 0.957, 95% CI 0.875–1.045, P = 0.327; recessive model, OR = 1.053, 95% CI 0.908–1.222, P = 0.495; allele model, OR = 0.987, 95% CI 0.919–1.059, P = 0.709). Subgroup analyses by ethnicity, menopausal status and study quality also revealed no statistically significant association (P > 0.05). In conclusion, our results showed that the ESR1 rs9340799 polymorphism was not associated with BC susceptibility, suggesting its limited potential as a genetic marker for BC.
AbstractList The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta-analysis. Eligible studies were identified from the Web of Science, PubMed, Scopus, China National Knowledge Infrastructure, VIP and Wanfang databases based on the predefined inclusion and exclusion criteria. The pooled odds ratio (OR) was then calculated under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). Combined results from 23 studies involving 34,721 subjects indicated a lack of significant association between the polymorphism and BC susceptibility (homozygous model, OR = 1.045, 95% CI 0.887-1.231, P = 0.601; heterozygous model, OR = 0.941, 95% CI 0.861-1.030, P = 0.186; dominant model, OR = 0.957, 95% CI 0.875-1.045, P = 0.327; recessive model, OR = 1.053, 95% CI 0.908-1.222, P = 0.495; allele model, OR = 0.987, 95% CI 0.919-1.059, P = 0.709). Subgroup analyses by ethnicity, menopausal status and study quality also revealed no statistically significant association (P > 0.05). In conclusion, our results showed that the ESR1 rs9340799 polymorphism was not associated with BC susceptibility, suggesting its limited potential as a genetic marker for BC.
Abstract The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta-analysis. Eligible studies were identified from the Web of Science, PubMed, Scopus, China National Knowledge Infrastructure, VIP and Wanfang databases based on the predefined inclusion and exclusion criteria. The pooled odds ratio (OR) was then calculated under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). Combined results from 23 studies involving 34,721 subjects indicated a lack of significant association between the polymorphism and BC susceptibility (homozygous model, OR = 1.045, 95% CI 0.887–1.231, P = 0.601; heterozygous model, OR = 0.941, 95% CI 0.861–1.030, P = 0.186; dominant model, OR = 0.957, 95% CI 0.875–1.045, P = 0.327; recessive model, OR = 1.053, 95% CI 0.908–1.222, P = 0.495; allele model, OR = 0.987, 95% CI 0.919–1.059, P = 0.709). Subgroup analyses by ethnicity, menopausal status and study quality also revealed no statistically significant association (P > 0.05). In conclusion, our results showed that the ESR1 rs9340799 polymorphism was not associated with BC susceptibility, suggesting its limited potential as a genetic marker for BC.
The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta-analysis. Eligible studies were identified from the Web of Science, PubMed, Scopus, China National Knowledge Infrastructure, VIP and Wanfang databases based on the predefined inclusion and exclusion criteria. The pooled odds ratio (OR) was then calculated under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). Combined results from 23 studies involving 34,721 subjects indicated a lack of significant association between the polymorphism and BC susceptibility (homozygous model, OR = 1.045, 95% CI 0.887–1.231, P = 0.601; heterozygous model, OR = 0.941, 95% CI 0.861–1.030, P = 0.186; dominant model, OR = 0.957, 95% CI 0.875–1.045, P = 0.327; recessive model, OR = 1.053, 95% CI 0.908–1.222, P = 0.495; allele model, OR = 0.987, 95% CI 0.919–1.059, P = 0.709). Subgroup analyses by ethnicity, menopausal status and study quality also revealed no statistically significant association (P > 0.05). In conclusion, our results showed that the ESR1 rs9340799 polymorphism was not associated with BC susceptibility, suggesting its limited potential as a genetic marker for BC.
The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta-analysis. Eligible studies were identified from the Web of Science, PubMed, Scopus, China National Knowledge Infrastructure, VIP and Wanfang databases based on the predefined inclusion and exclusion criteria. The pooled odds ratio (OR) was then calculated under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). Combined results from 23 studies involving 34,721 subjects indicated a lack of significant association between the polymorphism and BC susceptibility (homozygous model, OR = 1.045, 95% CI 0.887-1.231, P = 0.601; heterozygous model, OR = 0.941, 95% CI 0.861-1.030, P = 0.186; dominant model, OR = 0.957, 95% CI 0.875-1.045, P = 0.327; recessive model, OR = 1.053, 95% CI 0.908-1.222, P = 0.495; allele model, OR = 0.987, 95% CI 0.919-1.059, P = 0.709). Subgroup analyses by ethnicity, menopausal status and study quality also revealed no statistically significant association (P > 0.05). In conclusion, our results showed that the ESR1 rs9340799 polymorphism was not associated with BC susceptibility, suggesting its limited potential as a genetic marker for BC.The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta-analysis. Eligible studies were identified from the Web of Science, PubMed, Scopus, China National Knowledge Infrastructure, VIP and Wanfang databases based on the predefined inclusion and exclusion criteria. The pooled odds ratio (OR) was then calculated under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). Combined results from 23 studies involving 34,721 subjects indicated a lack of significant association between the polymorphism and BC susceptibility (homozygous model, OR = 1.045, 95% CI 0.887-1.231, P = 0.601; heterozygous model, OR = 0.941, 95% CI 0.861-1.030, P = 0.186; dominant model, OR = 0.957, 95% CI 0.875-1.045, P = 0.327; recessive model, OR = 1.053, 95% CI 0.908-1.222, P = 0.495; allele model, OR = 0.987, 95% CI 0.919-1.059, P = 0.709). Subgroup analyses by ethnicity, menopausal status and study quality also revealed no statistically significant association (P > 0.05). In conclusion, our results showed that the ESR1 rs9340799 polymorphism was not associated with BC susceptibility, suggesting its limited potential as a genetic marker for BC.
ArticleNumber 18619
Author Mohamad Hanif, Ezanee Azlina
Low, Teck Yew
Tan, Shing Cheng
Sharzehan, Mohamad Ayub Khan
Kord-Varkaneh, Hamed
Islam, Md Asiful
Author_xml – sequence: 1
  givenname: Shing Cheng
  surname: Tan
  fullname: Tan, Shing Cheng
  email: sctan@ukm.edu.my
  organization: UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia
– sequence: 2
  givenname: Teck Yew
  surname: Low
  fullname: Low, Teck Yew
  organization: UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia
– sequence: 3
  givenname: Ezanee Azlina
  surname: Mohamad Hanif
  fullname: Mohamad Hanif, Ezanee Azlina
  organization: UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia
– sequence: 4
  givenname: Mohamad Ayub Khan
  surname: Sharzehan
  fullname: Sharzehan, Mohamad Ayub Khan
  organization: UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia
– sequence: 5
  givenname: Hamed
  surname: Kord-Varkaneh
  fullname: Kord-Varkaneh, Hamed
  organization: Department of Clinical Nutrition and Dietetics, Student Research Committee, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences
– sequence: 6
  givenname: Md Asiful
  surname: Islam
  fullname: Islam, Md Asiful
  email: ayoncx70@yahoo.com
  organization: Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34545128$$D View this record in MEDLINE/PubMed
BookMark eNp9kk9vEzEQxVeoiJbSL8ABWeLSHhb8f-0LUlW1UKkSEpSz5fVOEkcbe7EdUMSXx0laaHuoL2t53vvp7cy8bg5CDNA0bwn-QDBTHzMnQqsWU9LqTjPRqhfNEcVctJRRevDgftic5LzE9QiqOdGvmkPGBReEqqPmz-0CUMqacdxpjaY4blYxTQufVyjOUKlVyCXFOQSUwMFUYkJ2nBYWnV5-_0bOUK0AsmFAvmRkc47O2-JjQL99WaA-gc0FORscJJTXeYvwvR992bxpXs7smOHk7nvc_Li6vL340t58_Xx9cX7TOsFxaWe9clI5kLJjmgzQS0ol09AzCowzKZxS2gJIPdCO9JI5EAKzTiiuWf1_dtxc77lDtEszJb-yaWOi9Wb3ENPc2FS8G8EQPVhFLO2csLwnpJIlHnqGO971vZOV9WnPmtb9CgYHoSQ7PoI-rgS_MPP4yyguaIdJBZzeAVL8ua69NStfmzKONkBcZ0NFJ3CHmcRV-v6JdBnXKdRWbVV1hEpzUVXvHib6F-V-xlWg9gKXYs4JZsb5shtRDehHQ7DZbpTZb5SpG2V2G2W2VvrEek9_1sT2plzFYQ7pf-xnXH8BxGvcbg
CitedBy_id crossref_primary_10_3389_bjbs_2024_11835
crossref_primary_10_1016_j_humgen_2023_201217
crossref_primary_10_3390_biomedicines11051374
crossref_primary_10_1371_journal_pone_0276313
crossref_primary_10_1007_s11916_024_01338_z
crossref_primary_10_1016_j_arr_2021_101554
crossref_primary_10_1016_j_ncrna_2024_09_006
crossref_primary_10_61186_ijbd_16_4_21
crossref_primary_10_3390_metabo12080673
crossref_primary_10_1007_s43032_022_00911_4
Cites_doi 10.1016/j.ejso.2004.02.010
10.1086/302727
10.12659/MSM.894010
10.1158/1055-9965.EPI-05-0485
10.1038/sj.bjc.6600008
10.1038/ng1474
10.1007/s13277-015-3868-2
10.1016/j.bbcan.2009.06.003
10.1152/physrev.00024.2016
10.1007/s00776-015-0725-5
10.1186/bcr811
10.1186/bcr938
10.1038/ng1955
10.1677/erc.1.01005
10.1016/S0960-0760(00)00104-7
10.1093/carcin/21.4.623
10.1093/jnci/94.18.1358
10.1093/jnci/91.11.943
10.31557/APJCP.2020.21.5.1363
10.1038/ng.2007.53
10.1002/ijc.21105
10.1073/pnas.1322057111
10.1093/jnci/94.8.606
10.1038/nrg.2017.101
10.1155/2012/915610
10.1093/carcin/19.1.1
10.1007/s11033-013-2611-6
10.1007/s00432-007-0244-7
10.1186/s12885-016-2804-1
10.1007/s10549-007-9497-8
10.35841/biomedicalresearch.30-18-1189
10.1093/oxfordjournals.jncimonographs.a024248
10.1016/j.bbrc.2017.04.105
10.1023/A:1024439202528
10.1016/j.cancergen.2017.01.004
10.7314/APJCP.2013.14.11.6743
10.1210/er.2018-00087
10.1007/s10549-006-9453-z
10.1007/s10552-005-0307-5
10.1093/hmg/ddn429
10.1016/S0304-3835(01)00861-8
10.1073/pnas.1421323111
10.4103/0973-1482.179109
10.1016/j.canep.2010.08.005
10.1007/s11033-014-3419-8
10.1159/000369045
10.1016/S1383-5742(03)00016-4
10.1038/aps.2014.123
10.1016/j.breast.2014.10.005
10.1002/cncr.11340
10.1002/jgm.3010
10.3322/caac.21557
10.1016/j.maturitas.2011.05.008
10.1038/ng.2563
10.1186/s12935-019-0727-z
10.1097/MD.0000000000010109
10.7555/JBR.31.20160087
10.1038/s41598-019-56847-4
10.1007/s10549-007-9562-3
ContentType Journal Article
Copyright The Author(s) 2021
2021. The Author(s).
The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: 2021. The Author(s).
– notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1038/s41598-021-97935-8
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic

Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ (Directory of Open Access Journals)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 12
ExternalDocumentID oai_doaj_org_article_19da81a27c5a4b1188960db30747bbc6
PMC8452701
34545128
10_1038_s41598_021_97935_8
Genre Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7XB
8FK
AARCD
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c540t-fb8c68ce667391deb622639eb32e34365c889aee69d271b63ce55037584933223
IEDL.DBID M48
ISSN 2045-2322
IngestDate Wed Aug 27 01:29:07 EDT 2025
Thu Aug 21 13:29:52 EDT 2025
Fri Jul 11 03:37:36 EDT 2025
Wed Aug 13 09:13:02 EDT 2025
Mon Jul 21 05:59:24 EDT 2025
Tue Jul 01 03:49:20 EDT 2025
Thu Apr 24 23:12:00 EDT 2025
Fri Feb 21 02:39:43 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2021. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-fb8c68ce667391deb622639eb32e34365c889aee69d271b63ce55037584933223
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-021-97935-8
PMID 34545128
PQID 2574548945
PQPubID 2041939
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_19da81a27c5a4b1188960db30747bbc6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8452701
proquest_miscellaneous_2575070360
proquest_journals_2574548945
pubmed_primary_34545128
crossref_citationtrail_10_1038_s41598_021_97935_8
crossref_primary_10_1038_s41598_021_97935_8
springer_journals_10_1038_s41598_021_97935_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-09-20
PublicationDateYYYYMMDD 2021-09-20
PublicationDate_xml – month: 09
  year: 2021
  text: 2021-09-20
  day: 20
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Zhang, Zhang, Li, Zhao, Yang (CR28) 2018; 97
Adlanmerini (CR52) 2014; 111
Modugno (CR40) 2005; 116
Yang (CR71) 2015; 20
Smith (CR2) 2019; 69
Jefcoate (CR15) 2000
Madeira (CR47) 2014; 41
Tan, Ismail, Duski, Othman, Ankathil (CR65) 2017; 211
Sierra-Martinez (CR45) 2018; 14
Peto (CR8) 1999; 91
Onland-Moret, van Gils, Roest, Grobbee, Peeters (CR39) 2005; 16
Atoum, Alzoughool (CR46) 2017; 9
Dai (CR44) 2019; 19
Arnal (CR54) 2017; 97
Comings, Gade-Andavolu, Cone, Muhleman, MacMurray (CR42) 2003; 97
Slattery (CR21) 2007; 105
Dunning, Healey, Pharoah, Teare, Ponder (CR22) 1999; 8
Kang (CR31) 2002; 178
Onland-Moret, Van Gils, Roest, Grobbee, Peeters (CR26) 2005; 16
Spielman (CR67) 2007; 39
Antoniou (CR9) 2002; 86
Shen, Li, Wu, Zhang, Gao (CR13) 2006; 15
Michailidou (CR10) 2013; 45
Thompson, Easton (CR5) 2002; 94
Fjeldheim (CR60) 2016; 16
Chauhan, Yadav, Kaushal, Kadian (CR63) 2019; 30
Dunning (CR35) 2009; 18
Craig Allred, Brown, Medina (CR56) 2004; 6
Sakoda (CR34) 2011; 35
Ramalhinho, Marques, Fonseca-Moutinho, Breitenfeld (CR33) 2013; 40
Koš, Reid, Denger, Gannon (CR48) 2001; 15
Wedrén (CR27) 2004; 6
Abdulrahman, Rahman (CR12) 2012; 2012
Lu (CR32) 2014; 14
Tan (CR11) 2020; 10
Tan, Ankathil (CR69) 2015; 36
Stratton, Rahman (CR7) 2008; 40
Kord-Varkaneh (CR14) 2020; 21
Goddard, Hopkins, Hall, Witte (CR68) 2000; 66
Shin (CR18) 2003; 80
Sun, Liang, Zhang, Wang, Yang (CR53) 2017; 487
Hu (CR61) 2017; 31
Molina-Montes (CR6) 2014; 23
Carrillo-Moreno (CR43) 2019; 24
Zhang (CR29) 2015; 21
Ikeda, Horie-Inoue, Inoue (CR51) 2015; 36
Gee (CR55) 2005; 12
Mitrunen, Hirvonen (CR4) 2003; 544
Whitesell (CR50) 2014; 111
Javed (CR25) 2011; 69
Jp, Ee, Ta (CR64) 2004; 36
Wang (CR36) 2007; 106
Balfe (CR20) 2004; 30
Zhu, Conney (CR16) 1998; 19
Cai (CR41) 2003; 12
Shen, Li, Wu, Zhang, Gao (CR37) 2006; 15
Chen, Russo (CR58) 2009; 1796
Timpson, Greenwood, Soranzo, Lawson, Richards (CR70) 2018; 19
Hu (CR3) 2007; 133
CR24
Andersen (CR30) 1994; 94
Mattei (CR66) 2009; 2009
Hewitt, Korach (CR49) 2018; 39
Weiderpass (CR23) 2000; 21
Tan (CR59) 2018; 20
Katzenellenbogen (CR19) 2000; 74
Key (CR17) 2002; 94
Lu, Li, Wei, Hua (CR38) 2005; 43
Louie, Sevigny (CR57) 2017; 7
Sapkota (CR1) 2014; 144
Lipphardt, Deryal, Ong, Schmidt, Mahlknecht (CR62) 2013; 6
X Hu (97935_CR61) 2017; 31
P Balfe (97935_CR20) 2004; 30
E Weiderpass (97935_CR23) 2000; 21
DE Comings (97935_CR42) 2003; 97
A Shin (97935_CR18) 2003; 80
AC Ramalhinho (97935_CR33) 2013; 40
Z Hu (97935_CR3) 2007; 133
J Peto (97935_CR8) 1999; 91
AC Antoniou (97935_CR9) 2002; 86
M Sierra-Martinez (97935_CR45) 2018; 14
TJ Key (97935_CR17) 2002; 94
AM Dunning (97935_CR35) 2009; 18
K Ikeda (97935_CR51) 2015; 36
TI Andersen (97935_CR30) 1994; 94
JF Arnal (97935_CR54) 2017; 97
MF Lipphardt (97935_CR62) 2013; 6
Y Sapkota (97935_CR1) 2014; 144
KP Madeira (97935_CR47) 2014; 41
D Craig Allred (97935_CR56) 2004; 6
H Kord-Varkaneh (97935_CR14) 2020; 21
NJ Timpson (97935_CR70) 2018; 19
97935_CR24
S Wedrén (97935_CR27) 2004; 6
JM Gee (97935_CR55) 2005; 12
SC Tan (97935_CR11) 2020; 10
Y Shen (97935_CR13) 2006; 15
Q Sun (97935_CR53) 2017; 487
NC Onland-Moret (97935_CR26) 2005; 16
SC Tan (97935_CR65) 2017; 211
NC Onland-Moret (97935_CR39) 2005; 16
J Wang (97935_CR36) 2007; 106
E Molina-Montes (97935_CR6) 2014; 23
M Adlanmerini (97935_CR52) 2014; 111
M Koš (97935_CR48) 2001; 15
BT Zhu (97935_CR16) 1998; 19
ZL Zhang (97935_CR28) 2018; 97
Z Dai (97935_CR44) 2019; 19
SC Hewitt (97935_CR49) 2018; 39
X Lu (97935_CR38) 2005; 43
P Chauhan (97935_CR63) 2019; 30
Y Zhang (97935_CR29) 2015; 21
Q Cai (97935_CR41) 2003; 12
MF Atoum (97935_CR46) 2017; 9
L Whitesell (97935_CR50) 2014; 111
FN Fjeldheim (97935_CR60) 2016; 16
RA Smith (97935_CR2) 2019; 69
AM Dunning (97935_CR22) 1999; 8
SC Tan (97935_CR69) 2015; 36
GO Abdulrahman (97935_CR12) 2012; 2012
K Mitrunen (97935_CR4) 2003; 544
SC Tan (97935_CR59) 2018; 20
F Modugno (97935_CR40) 2005; 116
M Yang (97935_CR71) 2015; 20
BS Katzenellenbogen (97935_CR19) 2000; 74
H Lu (97935_CR32) 2014; 14
DI Carrillo-Moreno (97935_CR43) 2019; 24
Y Shen (97935_CR37) 2006; 15
MR Stratton (97935_CR7) 2008; 40
LC Sakoda (97935_CR34) 2011; 35
HJ Kang (97935_CR31) 2002; 178
ML Slattery (97935_CR21) 2007; 105
KAB Goddard (97935_CR68) 2000; 66
I Jp (97935_CR64) 2004; 36
JQ Chen (97935_CR58) 2009; 1796
K Michailidou (97935_CR10) 2013; 45
MC Louie (97935_CR57) 2017; 7
CR Jefcoate (97935_CR15) 2000
J Mattei (97935_CR66) 2009; 2009
D Thompson (97935_CR5) 2002; 94
RS Spielman (97935_CR67) 2007; 39
S Javed (97935_CR25) 2011; 69
References_xml – volume: 30
  start-page: 469
  year: 2004
  end-page: 474
  ident: CR20
  article-title: Estrogen receptor α and β profiling in human breast cancer
  publication-title: Eur. J. Surg. Oncol.
  doi: 10.1016/j.ejso.2004.02.010
– volume: 66
  start-page: 216
  year: 2000
  ident: CR68
  article-title: Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations
  publication-title: Am. J. Hum. Genet.
  doi: 10.1086/302727
– volume: 21
  start-page: 2986
  year: 2015
  end-page: 2996
  ident: CR29
  article-title: Association between ESR1 PvuII, XbaI, and P325P polymorphisms and breast cancer susceptibility: A meta-analysis
  publication-title: Med. Sci. Monit.
  doi: 10.12659/MSM.894010
– volume: 15
  start-page: 342
  year: 2006
  end-page: 347
  ident: CR13
  article-title: Joint effects of the CYP1A1 MspI, ERα PvuII, and ERα XbaI polymorphisms on the risk of breast cancer: Results from a population-based case-control study in Shanghai, China
  publication-title: Cancer Epidemiol. Biomarkers Prev.
  doi: 10.1158/1055-9965.EPI-05-0485
– volume: 86
  start-page: 76
  year: 2002
  end-page: 83
  ident: CR9
  article-title: A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6600008
– volume: 36
  start-page: 1312
  year: 2004
  end-page: 1318
  ident: CR64
  article-title: ‘Racial’ differences in genetic effects for complex diseases
  publication-title: Nat. Genet.
  doi: 10.1038/ng1474
– volume: 36
  start-page: 2
  year: 2015
  ident: CR69
  article-title: Genetic susceptibility to cervical cancer: Role of common polymorphisms in apoptosis-related genes
  publication-title: Tumor Biol.
  doi: 10.1007/s13277-015-3868-2
– volume: 1796
  start-page: 162
  year: 2009
  end-page: 175
  ident: CR58
  article-title: ERα-negative and triple negative breast cancer: Molecular features and potential therapeutic approaches
  publication-title: Biochim. Biophys. Acta Rev. Cancer
  doi: 10.1016/j.bbcan.2009.06.003
– volume: 97
  start-page: 1045
  year: 2017
  end-page: 1087
  ident: CR54
  article-title: Membrane and nuclear estrogen receptor alpha actions: From tissue specificity to medical implications
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00024.2016
– volume: 31
  start-page: 213
  year: 2017
  end-page: 225
  ident: CR61
  article-title: Association of three single nucleotide polymorphisms of ESR1 with breast cancer susceptibility: A meta-analysis
  publication-title: J. Biomed. Res.
– volume: 20
  start-page: 593
  year: 2015
  end-page: 600
  ident: CR71
  article-title: The polymorphisms of melatonin receptor 1B gene (MTNR1B) (rs4753426 and rs10830963) and susceptibility to adolescent idiopathic scoliosis: A meta-analysis
  publication-title: J. Orthop. Sci.
  doi: 10.1007/s00776-015-0725-5
– volume: 6
  start-page: R437
  year: 2004
  end-page: R449
  ident: CR27
  article-title: Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study
  publication-title: Breast Cancer Res.
  doi: 10.1186/bcr811
– volume: 6
  start-page: 240
  year: 2004
  end-page: 245
  ident: CR56
  article-title: The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
  publication-title: Breast Cancer Res.
  doi: 10.1186/bcr938
– volume: 39
  start-page: 226
  year: 2007
  ident: CR67
  article-title: Common genetic variants account for differences in gene expression among ethnic groups
  publication-title: Nat. Genet.
  doi: 10.1038/ng1955
– volume: 12
  start-page: 2
  year: 2005
  ident: CR55
  article-title: Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer
  publication-title: Endocr. Relat. Cancer
  doi: 10.1677/erc.1.01005
– volume: 74
  start-page: 279
  year: 2000
  end-page: 285
  ident: CR19
  article-title: Molecular mechanisms of estrogen action: Selective ligands and receptor pharmacology
  publication-title: J. Steroid Biochem. Mol. Biol.
  doi: 10.1016/S0960-0760(00)00104-7
– volume: 21
  start-page: 623
  year: 2000
  end-page: 627
  ident: CR23
  article-title: Estrogen receptor α gene polymorphisms and endometrial cancer risk
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/21.4.623
– volume: 94
  start-page: 1358
  year: 2002
  end-page: 1365
  ident: CR5
  article-title: Cancer incidence in BRCA1 mutation carriers
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/94.18.1358
– volume: 91
  start-page: 943
  year: 1999
  end-page: 949
  ident: CR8
  article-title: Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/91.11.943
– volume: 12
  start-page: 853
  year: 2003
  end-page: 859
  ident: CR41
  article-title: Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: Results from the Shanghai Breast Cancer Study
  publication-title: Cancer Epidemiol. Biomarkers Prev.
– volume: 21
  start-page: 1363
  year: 2020
  end-page: 1367
  ident: CR14
  article-title: Association between healthy eating index-2015 and breast cancer risk: A case-control study
  publication-title: Asian Pacific J. Cancer Prev.
  doi: 10.31557/APJCP.2020.21.5.1363
– volume: 40
  start-page: 17
  year: 2008
  end-page: 22
  ident: CR7
  article-title: The emerging landscape of breast cancer susceptibility
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2007.53
– volume: 116
  start-page: 984
  year: 2005
  end-page: 991
  ident: CR40
  article-title: Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.21105
– volume: 97
  start-page: 1
  year: 2018
  ident: CR28
  article-title: Association between ERα gene Pvu II polymorphism and breast cancer susceptibility
  publication-title: Medicine
– volume: 24
  start-page: 1927
  year: 2019
  end-page: 1933
  ident: CR43
  article-title: Association of rs2234693 and rs9340799 polymorphisms of ESR1 gene in breast cancer of Mexican population
  publication-title: J. BUON.
– volume: 111
  start-page: 2
  year: 2014
  ident: CR52
  article-title: Mutation of the palmitoylation site of estrogen receptor a in vivo reveals tissue-specific roles for membrane versus nuclear actions
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1322057111
– volume: 94
  start-page: 606
  year: 2002
  end-page: 616
  ident: CR17
  article-title: Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/94.8.606
– volume: 19
  start-page: 110
  year: 2018
  end-page: 124
  ident: CR70
  article-title: Genetic architecture: the shape of the genetic contribution to human traits and disease
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg.2017.101
– volume: 10
  start-page: 1
  year: 2020
  end-page: 10
  ident: CR11
  article-title: Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: A meta-analysis
  publication-title: Sci. Rep.
– volume: 2012
  start-page: 2
  year: 2012
  ident: CR12
  article-title: Epidemiology of breast cancer in Europe and Africa
  publication-title: J. Cancer Epidemiol.
  doi: 10.1155/2012/915610
– volume: 43
  start-page: 290
  year: 2005
  end-page: 293
  ident: CR38
  article-title: The XbaI and PvuII gene polymorphisms of the estrogen receptor alpha gene in Chinese women with breast cancer
  publication-title: Zhonghua Wai Ke Za Zhi
– volume: 19
  start-page: 1
  year: 1998
  end-page: 27
  ident: CR16
  article-title: Functional role of estrogen metabolism in target cells: Review and perspectives
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/19.1.1
– volume: 40
  start-page: 5093
  year: 2013
  end-page: 5103
  ident: CR33
  article-title: Genetic polymorphims of estrogen receptor alpha -397 PvuII (T>C) and -351 XbaI (A>G) in a portuguese population: Prevalence and relation with breast cancer susceptibility
  publication-title: Mol. Biol. Rep.
  doi: 10.1007/s11033-013-2611-6
– volume: 133
  start-page: 969
  year: 2007
  end-page: 978
  ident: CR3
  article-title: A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives
  publication-title: J. Cancer Res. Clin. Oncol.
  doi: 10.1007/s00432-007-0244-7
– volume: 16
  start-page: 1
  year: 2016
  end-page: 12
  ident: CR60
  article-title: Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes
  publication-title: BMC Cancer
  doi: 10.1186/s12885-016-2804-1
– volume: 106
  start-page: 273
  year: 2007
  end-page: 280
  ident: CR36
  article-title: Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-007-9497-8
– volume: 30
  start-page: 2
  year: 2019
  ident: CR63
  article-title: Evaluation of genetic polymorphism in estrogen receptor? Gene as breast cancer risk
  publication-title: Biomed. Res.
  doi: 10.35841/biomedicalresearch.30-18-1189
– year: 2000
  ident: CR15
  article-title: Tissue-specific synthesis and oxidative metabolism of estrogens
  publication-title: J. Natl. Cancer Inst. Monogr.
  doi: 10.1093/oxfordjournals.jncimonographs.a024248
– volume: 15
  start-page: 342
  year: 2006
  end-page: 347
  ident: CR37
  article-title: Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: Results from a population-based case-control study in Shanghai, China
  publication-title: Cancer Epidemiol. Biomark. Prev.
  doi: 10.1158/1055-9965.EPI-05-0485
– volume: 487
  start-page: 625
  year: 2017
  end-page: 632
  ident: CR53
  article-title: ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2017.04.105
– volume: 80
  start-page: 127
  year: 2003
  end-page: 131
  ident: CR18
  article-title: Estrogen receptor alpha gene polymorphisms and breast cancer risk
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1023/A:1024439202528
– volume: 15
  start-page: 2057
  year: 2001
  end-page: 2063
  ident: CR48
  article-title: Minireview: Genomic organization of the human ERα gene promoter region
  publication-title: Mol. Endocrinol.
– volume: 211
  start-page: 2
  year: 2017
  ident: CR65
  article-title: FAS c-671A>G polymorphism and cervical cancer risk: A case–control study and meta-analysis
  publication-title: Cancer Genet.
  doi: 10.1016/j.cancergen.2017.01.004
– volume: 9
  start-page: 45
  year: 2017
  end-page: 49
  ident: CR46
  article-title: Reduction in breast cancer susceptibility due to XbaI gene polymorphism of alpha estrogen receptor gene in Jordanians
  publication-title: Breast Cancer
– volume: 14
  start-page: 6743
  year: 2014
  end-page: 6749
  ident: CR32
  article-title: Estrogen receptor alpha gene polymorphisms and breast cancer risk: A case–control study with meta-analysis combined
  publication-title: Asian Pac. J. Cancer Prev.
  doi: 10.7314/APJCP.2013.14.11.6743
– volume: 39
  start-page: 664
  year: 2018
  end-page: 675
  ident: CR49
  article-title: Estrogen receptors: New directions in the new millennium
  publication-title: Endocr. Rev.
  doi: 10.1210/er.2018-00087
– volume: 105
  start-page: 327
  year: 2007
  end-page: 335
  ident: CR21
  article-title: ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-006-9453-z
– volume: 16
  start-page: 1195
  year: 2005
  end-page: 1202
  ident: CR26
  article-title: The estrogen receptor a gene and breast cancer risk (The Netherlands)
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-005-0307-5
– volume: 18
  start-page: 1131
  year: 2009
  end-page: 1139
  ident: CR35
  article-title: Association of ESR1 gene tagging SNPs with breast cancer risk
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddn429
– volume: 7
  start-page: 1617
  year: 2017
  end-page: 1636
  ident: CR57
  article-title: Steroid hormone receptors as prognostic markers in breast cancer
  publication-title: Am. J. Cancer Res.
– volume: 178
  start-page: 175
  year: 2002
  end-page: 180
  ident: CR31
  article-title: Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk
  publication-title: Cancer Lett.
  doi: 10.1016/S0304-3835(01)00861-8
– volume: 111
  start-page: 18297
  year: 2014
  end-page: 18302
  ident: CR50
  article-title: HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1421323111
– volume: 16
  start-page: 1195
  year: 2005
  end-page: 1202
  ident: CR39
  article-title: The estrogen receptor alpha gene and breast cancer risk (The Netherlands)
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-005-0307-5
– volume: 2009
  start-page: 1
  issue: 10
  year: 2009
  end-page: 12
  ident: CR66
  article-title: Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites
  publication-title: BMC Genet.
– volume: 14
  start-page: 640
  year: 2018
  end-page: 646
  ident: CR45
  article-title: Predictive polymorphisms for breast cancer in postmenopausal Mexican women
  publication-title: J. Cancer Res. Ther.
  doi: 10.4103/0973-1482.179109
– volume: 35
  start-page: 48
  year: 2011
  end-page: 55
  ident: CR34
  article-title: Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women
  publication-title: Cancer Epidemiol.
  doi: 10.1016/j.canep.2010.08.005
– volume: 41
  start-page: 5459
  year: 2014
  end-page: 5466
  ident: CR47
  article-title: Estrogen receptor alpha (ERS1) SNPs c454–397T>C (PvuII) and c454–351A>G (XbaI) are risk biomarkers for breast cancer development
  publication-title: Mol. Biol. Rep.
  doi: 10.1007/s11033-014-3419-8
– volume: 144
  start-page: 77
  year: 2014
  end-page: 91
  ident: CR1
  article-title: Germline DNA variations in breast cancer predisposition and prognosis: A systematic review of the literature
  publication-title: Cytogenet. Genome Res.
  doi: 10.1159/000369045
– volume: 6
  start-page: 282
  year: 2013
  end-page: 288
  ident: CR62
  article-title: ESR1 single nucleotide polymorphisms predict breast cancer susceptibility in the central European Caucasian population
  publication-title: Int. J. Clin. Exp. Med.
– volume: 544
  start-page: 9
  year: 2003
  end-page: 41
  ident: CR4
  article-title: Molecular epidemiology of sporadic breast cancer: The role of polymorphic genes involved in oestrogen biosynthesis and metabolism
  publication-title: Mutat. Res. Rev. Mutat. Res.
  doi: 10.1016/S1383-5742(03)00016-4
– volume: 36
  start-page: 24
  year: 2015
  end-page: 31
  ident: CR51
  article-title: Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/aps.2014.123
– volume: 23
  start-page: 721
  year: 2014
  end-page: 742
  ident: CR6
  article-title: Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis
  publication-title: Breast
  doi: 10.1016/j.breast.2014.10.005
– volume: 97
  start-page: 2160
  year: 2003
  end-page: 2170
  ident: CR42
  article-title: A multigene test for the risk of sporadic breast carcinoma
  publication-title: Cancer
  doi: 10.1002/cncr.11340
– volume: 20
  start-page: e3010
  year: 2018
  ident: CR59
  article-title: Low penetrance genetic polymorphisms as potential biomarkers for colorectal cancer predisposition
  publication-title: J. Gene Med.
  doi: 10.1002/jgm.3010
– volume: 69
  start-page: 184
  year: 2019
  end-page: 210
  ident: CR2
  article-title: Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening
  publication-title: CA. Cancer J. Clin.
  doi: 10.3322/caac.21557
– volume: 8
  start-page: 843
  year: 1999
  end-page: 854
  ident: CR22
  article-title: A systematic review of genetic polymorphisms and breast cancer risk—PubMed
  publication-title: Cancer Epidemiol. Biomark. Prev.
– volume: 94
  start-page: 665
  year: 1994
  end-page: 670
  ident: CR30
  article-title: Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility
  publication-title: Hum. Genet.
– ident: CR24
– volume: 69
  start-page: 377
  year: 2011
  end-page: 382
  ident: CR25
  article-title: Combined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani population
  publication-title: Maturitas
  doi: 10.1016/j.maturitas.2011.05.008
– volume: 45
  start-page: 353
  year: 2013
  end-page: 361
  ident: CR10
  article-title: Large-scale genotyping identifies 41 new loci associated with breast cancer risk
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2563
– volume: 19
  start-page: 11
  year: 2019
  ident: CR44
  article-title: Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-019-0727-z
– volume: 21
  start-page: 1363
  year: 2020
  ident: 97935_CR14
  publication-title: Asian Pacific J. Cancer Prev.
  doi: 10.31557/APJCP.2020.21.5.1363
– volume: 94
  start-page: 606
  year: 2002
  ident: 97935_CR17
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/94.8.606
– volume: 41
  start-page: 5459
  year: 2014
  ident: 97935_CR47
  publication-title: Mol. Biol. Rep.
  doi: 10.1007/s11033-014-3419-8
– volume: 111
  start-page: 18297
  year: 2014
  ident: 97935_CR50
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1421323111
– volume: 105
  start-page: 327
  year: 2007
  ident: 97935_CR21
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-006-9453-z
– volume: 94
  start-page: 665
  year: 1994
  ident: 97935_CR30
  publication-title: Hum. Genet.
– volume: 15
  start-page: 342
  year: 2006
  ident: 97935_CR37
  publication-title: Cancer Epidemiol. Biomark. Prev.
  doi: 10.1158/1055-9965.EPI-05-0485
– volume: 39
  start-page: 664
  year: 2018
  ident: 97935_CR49
  publication-title: Endocr. Rev.
  doi: 10.1210/er.2018-00087
– volume: 30
  start-page: 2
  year: 2019
  ident: 97935_CR63
  publication-title: Biomed. Res.
  doi: 10.35841/biomedicalresearch.30-18-1189
– volume: 12
  start-page: 853
  year: 2003
  ident: 97935_CR41
  publication-title: Cancer Epidemiol. Biomarkers Prev.
– volume: 66
  start-page: 216
  year: 2000
  ident: 97935_CR68
  publication-title: Am. J. Hum. Genet.
  doi: 10.1086/302727
– volume: 35
  start-page: 48
  year: 2011
  ident: 97935_CR34
  publication-title: Cancer Epidemiol.
  doi: 10.1016/j.canep.2010.08.005
– volume: 16
  start-page: 1195
  year: 2005
  ident: 97935_CR26
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-005-0307-5
– volume: 97
  start-page: 1045
  year: 2017
  ident: 97935_CR54
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00024.2016
– volume: 8
  start-page: 843
  year: 1999
  ident: 97935_CR22
  publication-title: Cancer Epidemiol. Biomark. Prev.
– volume: 97
  start-page: 1
  year: 2018
  ident: 97935_CR28
  publication-title: Medicine
  doi: 10.1097/MD.0000000000010109
– volume: 2009
  start-page: 1
  issue: 10
  year: 2009
  ident: 97935_CR66
  publication-title: BMC Genet.
– volume: 74
  start-page: 279
  year: 2000
  ident: 97935_CR19
  publication-title: J. Steroid Biochem. Mol. Biol.
  doi: 10.1016/S0960-0760(00)00104-7
– volume: 1796
  start-page: 162
  year: 2009
  ident: 97935_CR58
  publication-title: Biochim. Biophys. Acta Rev. Cancer
  doi: 10.1016/j.bbcan.2009.06.003
– volume: 106
  start-page: 273
  year: 2007
  ident: 97935_CR36
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-007-9497-8
– volume: 39
  start-page: 226
  year: 2007
  ident: 97935_CR67
  publication-title: Nat. Genet.
  doi: 10.1038/ng1955
– volume: 31
  start-page: 213
  year: 2017
  ident: 97935_CR61
  publication-title: J. Biomed. Res.
  doi: 10.7555/JBR.31.20160087
– volume: 178
  start-page: 175
  year: 2002
  ident: 97935_CR31
  publication-title: Cancer Lett.
  doi: 10.1016/S0304-3835(01)00861-8
– volume: 12
  start-page: 2
  year: 2005
  ident: 97935_CR55
  publication-title: Endocr. Relat. Cancer
  doi: 10.1677/erc.1.01005
– volume: 15
  start-page: 2057
  year: 2001
  ident: 97935_CR48
  publication-title: Mol. Endocrinol.
– volume: 6
  start-page: 282
  year: 2013
  ident: 97935_CR62
  publication-title: Int. J. Clin. Exp. Med.
– volume: 69
  start-page: 184
  year: 2019
  ident: 97935_CR2
  publication-title: CA. Cancer J. Clin.
  doi: 10.3322/caac.21557
– volume: 19
  start-page: 1
  year: 1998
  ident: 97935_CR16
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/19.1.1
– volume: 94
  start-page: 1358
  year: 2002
  ident: 97935_CR5
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/94.18.1358
– volume: 544
  start-page: 9
  year: 2003
  ident: 97935_CR4
  publication-title: Mutat. Res. Rev. Mutat. Res.
  doi: 10.1016/S1383-5742(03)00016-4
– volume: 30
  start-page: 469
  year: 2004
  ident: 97935_CR20
  publication-title: Eur. J. Surg. Oncol.
  doi: 10.1016/j.ejso.2004.02.010
– volume: 19
  start-page: 11
  year: 2019
  ident: 97935_CR44
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-019-0727-z
– volume: 36
  start-page: 2
  year: 2015
  ident: 97935_CR69
  publication-title: Tumor Biol.
  doi: 10.1007/s13277-015-3868-2
– volume: 487
  start-page: 625
  year: 2017
  ident: 97935_CR53
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2017.04.105
– volume: 69
  start-page: 377
  year: 2011
  ident: 97935_CR25
  publication-title: Maturitas
  doi: 10.1016/j.maturitas.2011.05.008
– volume: 6
  start-page: R437
  year: 2004
  ident: 97935_CR27
  publication-title: Breast Cancer Res.
  doi: 10.1186/bcr811
– volume: 36
  start-page: 1312
  year: 2004
  ident: 97935_CR64
  publication-title: Nat. Genet.
  doi: 10.1038/ng1474
– volume: 144
  start-page: 77
  year: 2014
  ident: 97935_CR1
  publication-title: Cytogenet. Genome Res.
  doi: 10.1159/000369045
– volume: 14
  start-page: 640
  year: 2018
  ident: 97935_CR45
  publication-title: J. Cancer Res. Ther.
  doi: 10.4103/0973-1482.179109
– volume: 20
  start-page: e3010
  year: 2018
  ident: 97935_CR59
  publication-title: J. Gene Med.
  doi: 10.1002/jgm.3010
– volume: 45
  start-page: 353
  year: 2013
  ident: 97935_CR10
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2563
– volume: 2012
  start-page: 2
  year: 2012
  ident: 97935_CR12
  publication-title: J. Cancer Epidemiol.
  doi: 10.1155/2012/915610
– volume: 40
  start-page: 5093
  year: 2013
  ident: 97935_CR33
  publication-title: Mol. Biol. Rep.
  doi: 10.1007/s11033-013-2611-6
– volume: 21
  start-page: 623
  year: 2000
  ident: 97935_CR23
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/21.4.623
– volume: 86
  start-page: 76
  year: 2002
  ident: 97935_CR9
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6600008
– volume: 21
  start-page: 2986
  year: 2015
  ident: 97935_CR29
  publication-title: Med. Sci. Monit.
  doi: 10.12659/MSM.894010
– volume: 16
  start-page: 1195
  year: 2005
  ident: 97935_CR39
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-005-0307-5
– volume: 97
  start-page: 2160
  year: 2003
  ident: 97935_CR42
  publication-title: Cancer
  doi: 10.1002/cncr.11340
– volume: 10
  start-page: 1
  year: 2020
  ident: 97935_CR11
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-56847-4
– volume: 91
  start-page: 943
  year: 1999
  ident: 97935_CR8
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/91.11.943
– volume: 111
  start-page: 2
  year: 2014
  ident: 97935_CR52
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1322057111
– volume: 18
  start-page: 1131
  year: 2009
  ident: 97935_CR35
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddn429
– volume: 116
  start-page: 984
  year: 2005
  ident: 97935_CR40
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.21105
– volume: 19
  start-page: 110
  year: 2018
  ident: 97935_CR70
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg.2017.101
– volume: 133
  start-page: 969
  year: 2007
  ident: 97935_CR3
  publication-title: J. Cancer Res. Clin. Oncol.
  doi: 10.1007/s00432-007-0244-7
– year: 2000
  ident: 97935_CR15
  publication-title: J. Natl. Cancer Inst. Monogr.
  doi: 10.1093/oxfordjournals.jncimonographs.a024248
– volume: 24
  start-page: 1927
  year: 2019
  ident: 97935_CR43
  publication-title: J. BUON.
– volume: 15
  start-page: 342
  year: 2006
  ident: 97935_CR13
  publication-title: Cancer Epidemiol. Biomarkers Prev.
  doi: 10.1158/1055-9965.EPI-05-0485
– volume: 43
  start-page: 290
  year: 2005
  ident: 97935_CR38
  publication-title: Zhonghua Wai Ke Za Zhi
– volume: 6
  start-page: 240
  year: 2004
  ident: 97935_CR56
  publication-title: Breast Cancer Res.
  doi: 10.1186/bcr938
– volume: 14
  start-page: 6743
  year: 2014
  ident: 97935_CR32
  publication-title: Asian Pac. J. Cancer Prev.
  doi: 10.7314/APJCP.2013.14.11.6743
– ident: 97935_CR24
  doi: 10.1007/s10549-007-9562-3
– volume: 211
  start-page: 2
  year: 2017
  ident: 97935_CR65
  publication-title: Cancer Genet.
  doi: 10.1016/j.cancergen.2017.01.004
– volume: 80
  start-page: 127
  year: 2003
  ident: 97935_CR18
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1023/A:1024439202528
– volume: 7
  start-page: 1617
  year: 2017
  ident: 97935_CR57
  publication-title: Am. J. Cancer Res.
– volume: 40
  start-page: 17
  year: 2008
  ident: 97935_CR7
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2007.53
– volume: 36
  start-page: 24
  year: 2015
  ident: 97935_CR51
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/aps.2014.123
– volume: 23
  start-page: 721
  year: 2014
  ident: 97935_CR6
  publication-title: Breast
  doi: 10.1016/j.breast.2014.10.005
– volume: 9
  start-page: 45
  year: 2017
  ident: 97935_CR46
  publication-title: Breast Cancer
– volume: 16
  start-page: 1
  year: 2016
  ident: 97935_CR60
  publication-title: BMC Cancer
  doi: 10.1186/s12885-016-2804-1
– volume: 20
  start-page: 593
  year: 2015
  ident: 97935_CR71
  publication-title: J. Orthop. Sci.
  doi: 10.1007/s00776-015-0725-5
SSID ssj0000529419
Score 2.407394
SecondaryResourceType review_article
Snippet The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have...
The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have...
Abstract The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 18619
SubjectTerms 631/208
631/67
692/4028/67/1347
692/4028/67/1857
692/4028/67/68
692/53/2421
692/53/2423
692/699/67/1347
Adult
Alleles
Breast cancer
Breast Neoplasms - genetics
Estrogen Receptor alpha - genetics
Estrogen receptors
Estrogens
Female
Gene polymorphism
Genetic Association Studies
Genetic markers
Genetic Predisposition to Disease
Humanities and Social Sciences
Humans
Menopause
Meta-analysis
Middle Aged
multidisciplinary
Polymorphism
Polymorphism, Single Nucleotide
Science
Science (multidisciplinary)
Statistical analysis
Susceptibility
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDeBggaJAwiixrEd20dArSokOACVerP8ilipJKtN9lD1z3fsZLddnheusZ2MZsaebzLjGUJeyjo4WtNQ-lr6kjt0WG2UsrQyItoIKrD8M-fT5-b4hH88FafXWn2lnLCpPPDEuAOqg1XU4puE5Q7hsELMHRxLhd-d87nYNtq8a87UVNW71pzq-ZZMxdTBgJYq3SZLGQmok6JUO5YoF-z_Hcr8NVnyp4hpNkRHd8jtGUHCu4nyu-RG7O6Rm1NPyfP75AIFD6tBM_ShtIZlf4bePTJzMfyAvgXEe4AfXvWoOICnXVyi0w35xi28Ovz6hb4GHIlguwCLcQB7JT5I_2zBpSz2EXzSlhUM6yHnxeQU2_MH5OTo8NuH43LusFB6RGpj2TrlG-Vj6v2paYiuQTTGNDrYdWScNcIju22MjQ61pK5hPqJHw9DH4JrhUcAekr2u7-JjAm20tg3WC4crZctVWwWRogcUzbByoSB0w23j5_LjqQvGmclhcKbMJCGDEjJZQkYV5M12zXIqvvHX2e-TELczU-Hs_ADVyczqZP6lTgXZ36iAmXfzYPBY4-jZaS4K8mI7jPswBVdsF_t1niPS8dlUBXk0acyWEoarEVghhXJHl3ZI3R3pFt9zrW_FRS0rWpC3G627IuvPrHjyP1jxlNyq03ZJIbhqn-yNq3V8hghsdM_zZrsE2MorBQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96Ivgifls9JYIPipZrmrRJnkTljkPQB_Vg30K-qgtnu7bdh8N_3pm0u8v6ca-bhGYzv5nMV2YIeS7L4FjJQu5L6XPhwGC1UcrcygjaRlCBJ2fOx0_16Zn4sKgWs8NtmNMqNzIxCerQefSRHwG0BGjXWlRvVj9z7BqF0dW5hcZVcg1LlyGq5UJufSwYxRJMz29lCq6OBriv8E0Z5iUAMqtc7d1HqWz_v3TNv1Mm_4ibpuvo5Ba5OeuR9O1E-NvkSmzvkOtTZ8mLu-QXkJ_2g-ZgSWlNV9052PhwpMvhB-0aClofhQ_3HcCHgsyLKzC9aXp3S18cf_nMXlIYidS2gS7HgdodESl6bqnDXPaResRMT4f1kLJjUqLtxT1ydnL89f1pPvdZyD3oa2PeOOVr5SN2ANUsRFeDTsY1mNll5ILXlVdK2xhrHUrJXM19BLuGg6UhNAeBwO-Tg7Zr40NCm2htE6yvHKyUjVBNESqMITC4jJULGWGb0zZ-LkKOvTDOTQqGc2UmChmgkEkUMiojr7ZrVlMJjktnv0Mibmdi-ez0Q9d_MzM3GqaDVcwCPCsrHNhYCgy54Dh2E3DO1xk53EDAzDw9mB0CM_JsOwzciCEW28ZuneZUKETrIiMPJsRsd8JhNahXsEO5h6W9re6PtMvvqeK3ElUpC5aR1xvU7bb1_6N4dPm_eExulMgIGGIrDsnB2K_jE9CwRvc0sdFvcy4i9w
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VVkhcEG8CBRmJAwgi4thJ7OOCWlUrwYFSqTfLr9CVSrJKsoeKP8_YSbZaKEhcY1uxPJ_H83nGMwCvq9wZmlOX2ryyKTdIWLWvqlRXHq0NJxyLlzmfv5QnZ3x5XpzvQT6_hYlB-zGlZVTTc3TYhx4PmvAYLAQUIKSKVNyCg5CqHbF9sFgsT5fbm5Xgu-JUTi9kMiZuGLxzCsVk_TdZmH8GSv7mLY2H0PE9uDtZj2Qxzvc-7PnmAdwe60lePYSfKHTS9ZIhf5KSrNtLZPa4kKv-B2lrgrYewR93LYKGoKbzayTcJL62JW-OTr_StwRbPNGNI6uhJ_padCTc1xITItgHYgNSOtJv-hgTE8Nrrx7B2fHRt08n6VRdIbVopQ1pbYQthfWh7qekzpsSLTEmkVznnnFWFlYIqb0vpcsrakpmPbIZhvyCS4ZqgD2G_aZt_FMgtde6dtoWBkdWNRd15orgOaB4BAvjEqDzais7pR4PFTAuVXSBM6FGCSmUkIoSUiKBd9sx6zHxxj97fwxC3PYMSbPjh7b7riYQKSqdFlQjKAvNDTIrgfTNGRZqCBhjywQOZwioaSf3ClUaR1YneZHAq20z7sHgWNGNbzexTxFUZ5kl8GREzHYmDEejUYUzrHawtDPV3ZZmdRHzfAte5FVGE3g_o-56Wn9fimf_1_053MnDxgiOtuwQ9odu41-gnTWYl9PG-gVwHCIq
  priority: 102
  providerName: Springer Nature
Title The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility
URI https://link.springer.com/article/10.1038/s41598-021-97935-8
https://www.ncbi.nlm.nih.gov/pubmed/34545128
https://www.proquest.com/docview/2574548945
https://www.proquest.com/docview/2575070360
https://pubmed.ncbi.nlm.nih.gov/PMC8452701
https://doaj.org/article/19da81a27c5a4b1188960db30747bbc6
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEF_uA-VexG-jZ1nBB0VzdrNJdvdBpFd6HIU75M5C38J-RQs1qUkLFv95ZzdJz2r1wafAfpBl5zc7MzuzMwi9ZJFRJCIm1BHTYazAYJWWsVAyC9qG4Yb6y5yLy_R8Eo-nyXQPdeWO2g2sd5p2rp7UpJqffP-2_gAM_755Ms7f1SCE3EMxF2wAcEtCvo8OQTIxV9HgolX3m1zfkYiJaN_O7J56hG7TGNQK4uqz_yKqfEb_XWron9GUv7lUvaQ6u4vutComHjSYuIf2bHEf3WqKTq4foB-ADFzVgoKRJQRelHMw_2G3Z_VXXOYYFEIMP65KQBaG49AuwCrH_kkufjW6viKvMfRYLAuDZ8sayxv6Ynepi5ULc19i7eBU4XpV-8AZH4O7fogmZ6NPw_OwLcEQalDllmGuuE65tq44qCDGqhTUNSrAAo8sjWmaaM6FtDYVJmJEpVRbMHkoGCGxoHBW0EfooCgL-wTh3EqZG6kTBTNZHvO8bxLnXiAgp7kyASLdbme6zU_uymTMM-8npzxriJUBsTJPrIwH6M1mzqLJzvHP0aeOiJuRLrO2byirz1nLqBkRRnIiAbmJjBWYXxxsPKOoKzSglE4DdNxBIOvQmsG5B5jhIk4C9GLTDYzqvC-ysOXKj0nc-Zr2A_S4QcxmJR3iAsS2sLS11O2eYvbFJwPncRKxPgnQ2w51N8v6-1Y8_e8fPUNHkWMX55jrH6ODZbWyz0EvW6oe2mdT1kOHg8H4egzf09HlxytoHabDnr_r6Hl2_Ak0mTlK
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgQXxJtAASOBBIKoSZzEzgEhHq229HGAVtqb8SuwUpssya7Qiv_Eb2TGSXa1PHrrNbYVJ_PN-BvP2EPIU55YHSexDU3CTZhqcFiV4zxU3AHbsMIyv5lzeJSPTtKP42y8QX4NZ2EwrXKwid5Q29rgHvk2QCsFdl2k2Zvp9xCrRmF0dSih0cFi3y1-gMvWvt77APJ9liS7O8fvR2FfVSA0wE5mYamFyYVxWO-yiK3TOTAQVoBTmTiWsjwzQhTKubywCY91zowDFs-AV6fg_Cd40QGY_Euw8Ebo7PExX-7pYNQsjYv-bE7ExHYL6yOeYcM8CNCELBRr658vE_Avbvt3iuYfcVq__O1eJ9d63krfdkC7QTZcdZNc7ipZLm6RnwA32rQFA8-tKOi0Pl2c1SDCSXtG65ICy6Tw4qYGuFKwsW4Krj7153zp853Pn-IXFFocVZWlk1lL1Qo0FHeKqcbc-Rk1iNGGtvPWZ-P4xN7FbXJyIRK4QzarunL3CC2dUqVVJtMwkpepKCObYcwihsVfaBuQePjb0vSXnmPtjVPpg-9MyE5CEiQkvYSkCMjL5Zhpd-XHub3foRCXPfG6bv-gbr7KXvtlXFglYgXqkKlUg08nwHG0mmH1Aq1NHpCtAQKytyGtXCE-IE-WzaD9GNJRlavnvk-GRjuPAnK3Q8xyJgxGA52DGfI1LK1Ndb2lmnzzN4yLNEt4FAfk1YC61bT-_yvun_8Vj8mV0fHhgTzYO9p_QK4mqBQY3ou2yOasmbuHwO5m-pFXKUq-XLQO_wa5Ol3w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTiBeEN8EBhgJJBBEreN8OA8IMdZqYzBNg0l7M_4KVNqS0rRCFf8Zfx1nJ2lVPva219hu3Nzvzr_znX0AT7PIKBpRE-oo02Gs0GGVNstCmVlkG4Yb5jdzPh6ku8fx-5PkZAN-dWdhXFplZxO9oTaVdnvkfYRWjOw6j5N-0aZFHO6M3ky-h66ClIu0duU0Gojs28UPdN_q13s7KOtnUTQafn63G7YVBkKNTGUWForrlGvral_m1FiVIhthOTqYkWUxSxPNeS6tTXMTZVSlTFtk9Aw5dpwzVAWGv3sJNjPnFfVgc3t4cHi03OFxMbSY5u1JnQHj_RpXS3eizWVFoF4kIV9bDX3RgH8x3b8TNv-I2vrFcHQdrrUslrxtYHcDNmx5Ey43dS0Xt-Ango9M65zhjPOcTKrTxVmFAh3XZ6QqCHJOgi-eVgheghbXTtDxJ_7UL3k-_HREXxBssUSWhoxnNZErCBG3b0yUy6SfEe0QOyX1vPa5OT7Nd3Ebji9EBnegV1alvQeksFIWRupE4cisiHkxMImLYFCkAlyZAGj3tYVur0B3lThOhQ_FMy4aCQmUkPASEjyAl8sxk-YCkHN7bzshLnu6y7v9g2r6VbS2QNDcSE4lKkciY4UeHkc30ijmahkopdMAtjoIiNai1GKF_wCeLJvRFrgAjyxtNfd9EmfC00EAdxvELGfCcDSSO5xhtoaltamut5Tjb_6-cR4nUTagAbzqULea1v8_xf3z_8VjuIL6Kz7sHew_gKuR0wkX6xtsQW82nduHSPVm6lGrUwS-XLQa_wZApmOL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+rs9340799+polymorphism+of+the+estrogen+receptor+alpha+%28ESR1%29+gene+and+its+association+with+breast+cancer+susceptibility&rft.jtitle=Scientific+reports&rft.au=Tan%2C+Shing+Cheng&rft.au=Low%2C+Teck+Yew&rft.au=Mohamad+Hanif%2C+Ezanee+Azlina&rft.au=Sharzehan%2C+Mohamad+Ayub+Khan&rft.date=2021-09-20&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=11&rft_id=info:doi/10.1038%2Fs41598-021-97935-8&rft_id=info%3Apmid%2F34545128&rft.externalDocID=PMC8452701
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon